Genomma Lab Internacional, S.A.B. de C.V. GNMLF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 6.11% | 8.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.11% | 8.63% | |||
| Cost of Revenue | 2.81% | 1.83% | |||
| Gross Profit | 8.02% | 12.99% | |||
| SG&A Expenses | 11.38% | 17.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -193.04% | -102.69% | |||
| Total Operating Expenses | 7.34% | 7.53% | |||
| Operating Income | 1.45% | 13.02% | |||
| Income Before Tax | -16.04% | 18.04% | |||
| Income Tax Expenses | 8.43% | -35.67% | |||
| Earnings from Continuing Operations | -23.43% | 57.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.43% | 57.88% | |||
| EBIT | 1.45% | 13.02% | |||
| EBITDA | 1.39% | 11.61% | |||
| EPS Basic | -24.48% | 59.34% | |||
| Normalized Basic EPS | -17.37% | 18.00% | |||
| EPS Diluted | -24.48% | 59.34% | |||
| Normalized Diluted EPS | -17.37% | 18.00% | |||
| Average Basic Shares Outstanding | 1.61% | -0.84% | |||
| Average Diluted Shares Outstanding | 1.61% | -0.84% | |||
| Dividend Per Share | -- | 4.59% | |||
| Payout Ratio | 0.32% | -0.34% | |||